Symbiotec Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE899I01028
  • NSEID: SYMBIOTEC
  • BSEID: 544889
INR
1,598.75
-3.9 (-0.24%)
BSENSE

Nov 20

BSE+NSE Vol: 20533

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10040119,
    "name": "Symbiotec Pharma",
    "stock_name": "Symbiotec Pharma",
    "full_name": "Symbiotec Pharmalab Ltd",
    "name_url": "stocks-analysis/symbiotec-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,598.75",
    "chg": -3.9,
    "chgp": "-0.24%",
    "dir": -1,
    "prev_price": "1,602.65",
    "mcapval": "10,485.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 544889,
    "symbol": "SYMBIOTEC",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE899I01028",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": 20533,
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/symbiotec-pharma-10040119-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "10040119",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/symbiotec-pharmalab-10040119"
  },
  "announcements": [
    {
      "caption": "Intimation Regarding Change In Corporate Identification Number (CIN) And Listing Status Of The Company.",
      "datetime": "17-Nov-2026",
      "details": "Intimation regarding change in Corporate Identification Number (CIN) and Listing Status of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "12-Nov-2026",
      "details": "Pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time we would like to inform you that the officials of the Company will be attending an Investor",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "12-Nov-2026",
      "details": "Transcript of the Earnings conference call for the Analysts and Investors for the Quarter and Half year ended",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Intimation Regarding Change In Corporate Identification Number (CIN) And Listing Status Of The Company.

17-Nov-2026 | Source : BSE

Intimation regarding change in Corporate Identification Number (CIN) and Listing Status of the Company.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

12-Nov-2026 | Source : BSE

Pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time we would like to inform you that the officials of the Company will be attending an Investor

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

12-Nov-2026 | Source : BSE

Transcript of the Earnings conference call for the Analysts and Investors for the Quarter and Half year ended

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available